Rights and permissions
About this article
Cite this article
EMEA recommends suspension of Bextra marketing in the EU. Inpharma Wkly. 1494, 20 (2005). https://doi.org/10.2165/00128413-200514940-00048
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514940-00048